Twist and p53 reciprocally regulate target genes via direct interaction

Alexander NR, Tran NL, Rekapally H, Summers CE, Glackin C, Heimark RL . (2006). N-cadherin gene expression in prostate carcinoma is modulated by integrin-dependent nuclear translocation of Twist1. Cancer Res 66: 3365–3369.

Castanon I, Setina SV, Kass J, Baylies MK . (2001). Dimerization partners determine the activity of the Twist bHLH protein during Drosophila mesoderm development. Development 128: 3145–3159.

Chen ZF, Behringer RR . (1995). Twist is required in head mesenchyme for cranial neural tube morphogenesis. Genes Dev 15: 686–699.

El-Deiry WS, Harper JW, O’Connor PM, Velculescu VE, Canman CE, Jackman J et al. (1995). WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 54: 1169–1174.

El Ghouzzi V, Le Merrer M, Perrin-Schmitt F, Lajeunie E, Benit P, Renier D et al. (1997). Mutations of the TWIST gene in the Saethre–Chotzen syndrome. Nat Genet 15: 42–46.

Funato N, Ohtani K, Ohyama K, Kuroda T, Nakamura M . (2001). Common regulation of growth arrest and differentiation of osteoblasts by helix-loop-helix factors. Mol Cell Biol 21: 7416–7428.

Hamamori Y, Sartorelli V, Ogryzko V, Puri PL, Wu HY, Wang JY et al. (1999). Regulation of histone acetyltransferases p300 and PCAF by the bHLH protein Twist and adenoviral oncoprotein E1A. Cell 96: 405–413.

Hamamori Y, Wu HY, Sartorelli V, Kedes L . (1997). The basic domain of myogenic basic helix-loop-helix (bHLH) proteins is the noble target for direct inhibition by another bHLH protein, Twist. Mol Cell Biol 17: 6563–6573.

Howard TD, Paznekas WA, Green ED, Chiang L, Ma N, Ortiz De Luna RI et al. (1997). Mutations in TWIST, a basic helix-loop-helix transcription factor, in Saethre–Chotzen syndrome. Nat Genet 15: 36–41.

Igarashi T, Izumi H, Uchiumi T, Nishio T, Arao T, Tanabe M et al. (2007). Clock and ATF4 transcription system regulates drug resistance in human cancer cell lines. Oncogene 26: 4749–4760.

Imamura T, Izumi H, Nagatani G, Ise T, Nomoto M, Iwamoto Y et al. (2001). Interaction with p53 enhances binding of cisplatin-modified DNA by high mobility group 1 protein. J Biol Chem 276: 7534–7540.

Izumi H, Imamura T, Nagatani G, Ise T, Murakami T, Uramoto H et al. (2001). Y box-binding protein-1 binds preferentially to single-stranded nucleic acids and exhibits 3′ → 5′ exonuclease activity. Nucleic Acids Res 29: 1200–1207.

Izumi H, Ohta R, Nagatani G, Ise T, Nakayama Y, Nomoto M et al. (2003). p300/CBP-associated factor (P/CAF) interacts with nuclear respiratory factor-1 to regulate the UDP-N-acetyl-α-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase-3 gene. Biochem J 373: 713–722.

Jayaraman L, Moorthy NC, Murthy KG, Manley JL, Bustin M, Prives C . (1998). High mobility group protein-1 (HMG-1) is a unique activator of p53. Genes Dev 12: 462–472.

Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, Valent A et al. (1997). Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90: 809–819.

Kohno K, Uchiumi T, Niina I, Wakasugi T, Igarashi T, Momii Y et al. (2005). Transcription factors and drug resistance. Eur J Cancer 41: 2577–2586.

Lee YM, Park T, Schulz RA, Kim Y . (1997). Twist-mediated activation of the NK-4 homeobox gene in the visceral mesoderm of Drosophila requires two distinct clusters of E-box regulatory elements. J Biol Chem 272: 17531–17541.

Liu L, Scolnick DM, Trievel RC, Zhang HB, Marmorstein R, Halazonetis TD et al. (1999). p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage. Mol Cell Biol 19: 1202–1209.

Maestro R, Dei Tos AP, Hamamori Y, Krasnokutsky S, Sartorelli V, Kedes L et al. (1999). Twist is a potential oncogene that inhibits apoptosis. Genes Dev 13: 2207–2217.

Ohga T, Koike K, Ono M, Makino Y, Itagaki Y, Tanimoto M et al. (1996). Role of the human Y box-binding protein YB-1 in cellular sensitivity to the DNA-damaging agents cisplatin, mitomycin C, and ultraviolet light. Cancer Res 56: 4224–4228.

Okamoto T, Izumi H, Imamura T, Takano H, Ise T, Uchiumi T et al. (2000). Direct interaction of p53 with the Y-box binding protein, YB-1: a mechanism for regulation of human gene expression. Oncogene 19: 6194–6202.

Quertermous EE, Hidai H, Blanar MA, Quertermous T . (1994). Cloning and characterization of a basic helix-loop-helix protein expressed in early mesoderm and the developing somites. Proc Natl Acad Sci USA 91: 7066–7070.

Shiota M, Izumi H, Onitsuka T, Miyamoto N, Kashiwagi E, Kidani A et al. (2008). Twist promotes tumor cell growth through YB-1 expression. Cancer Res 68: 98–105.

Soo K, O’Rourke MP, Khoo PL, Steiner KA, Wong N, Behringer RR et al. (2002). Twist function is required for the morphogenesis of the cephalic neural tube and the differentiation in the mouse embryo. Dev Biol 247: 251–270.

Stasinopoulos IA, Mironchik Y, Raman A, Wildes F, Winnard P, Raman V . (2005). HOXA5-Twist interaction alters p53 homeostasis in breast cancer cells. J Biol Chem 280: 2294–2299.

Thisse B, Stoetzel C, Gorostiza-Thisse C, Perrin-Schmitt F . (1988). Sequence of the twist gene and nuclear localization of its protein in endomesodermal cells of early Drosophila embryos. EMBO J 7: 2175–2183.

Torigoe T, Izumi H, Ishiguchi H, Yoshida Y, Tanabe M, Yoshida T et al. (2005). Cisplatin resistance and transcription factors. Curr Med Chem Anticancer Agents 5: 15–27.

Uramoto H, Izumi H, Ise T, Tada M, Uchiumi T, Kuwano M et al. (2002). p73 interacts with c-Myc to regulate Y-box-binding protein-1 expression. J Biol Chem 227: 31694–31702.

Uramoto H, Izumi H, Nagatani G, Ohmori H, Nagasue N, Ise T et al. (2003). Physical interaction of tumour suppressor p53/p73 with CCAAT-binding transcription factor 2 (CTF2) and differential regulation of human high-mobility group 1 (HMG1) gene expression. Biochem J 371: 301–310.

Valsesia-Wittmann S, Magdeleine M, Dupasquier S, Garin E, Jallas AC, Combaret V et al. (2004). Oncogenic cooperation between H-Twist and N-Myc overrides failsafe programs in cancer cells. Cancer Cell 6: 625–630.

Wakasugi T, Izumi H, Uchiumi T, Suzuki H, Arao T, Nishio K et al. (2007). ZNF143 interacts with p73 and is involved in cisplatin resistance through the transcriptional regulation of DNA repair genes. Oncogene 26: 5194–5203.

Wang X, Ling MT, Guan XY, Tsao SW, Cheung HW, Lee DT et al. (2004). Identification of a novel function of TWIST1, bHLH protein, in the development of acquired taxol resistance in human cancer cells. Oncogene 23: 474–482.

Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C et al. (2004). Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117: 927–939.